Inhibition of endothelial nitric oxide synthase by the lipid phosphatase PTEN

Vascular Pharmacology

Volumn 52, Issue 5-6, 2010, Pages 191-198

  Church, Jarrod E ^a   Qian, Jin ^a   Kumar, Sanjiv ^a   Black, Stephen M ^a   Venema, Richard C ^a   Papapetropoulos, Andreas ^b   Fulton, David J R ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Akt; eNOS; Nitric oxide; PTEN; Vascular

Indexed keywords

ALANINE; BETA GALACTOSIDASE; CYSTEINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INOSITOL 1,4,5 TRISPHOSPHATE 5 PHOSPHATASE; MUTANT PROTEIN; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SUPEROXIDE; TYROSINE;

ACYLATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; AORTA; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; TRANSFECTION;

EID: 77951022204     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.11.007     Document Type: Article

References (35)

1. Bauer P.M., Fulton D., Boo Y.C., Sorescu G.P., Kemp B.E., Jo H., and Sessa W.C. Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J. Biol. Chem. 278 (2003) 14841-14849
2. Bucci M., Gratton J.P., Rudic R.D., Acevedo L., Roviezzo F., Cirino G., and Sessa W.C. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 6 (2000) 1362-1367
3. Chen C.A., Druhan L.J., Varadharaj S., Chen Y.R., and Zweier J.L. Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. J. Biol. Chem. 283 (2008) 27038-27047
4. Church J.E., and Fulton D. Differences in eNOS activity because of subcellular localization are dictated by phosphorylation state rather than the local calcium environment. J. Biol. Chem. 281 (2006) 1477-1488
5. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605
6. Dudzinski D.M., and Michel T. Life history of eNOS: partners and pathways. Cardiovasc. Res. 75 (2007) 247-260
7. Dutil E.M., Toker A., and Newton A.C. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol. 8 (1998) 1366-1375
8. Fleming I., Fisslthaler B., Dimmeler S., Kemp B.E., and Busse R. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ. Res. 88 (2001) E68-E75
9. Forstermann U., and Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113 (2006) 1708-1714
10. Fujino H., Salvi S., and Regan J.W. Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Mol. Pharmacol. 68 (2005) 251-259 10.1124/mol.105.011833
11. Fukumura D., Gohongi T., Kadambi A., Izumi Y., Ang J., Yun C.O., Buerk D.G., Huang P.L., and Jain R.K. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2604-2609
12. Fulton D., Church J.E., Ruan L., Li C., Sood S.G., Kemp B.E., Jennings I.G., and Venema R.C. Src kinase activates endothelial nitric-oxide synthase by phosphorylating Tyr-83. J. Biol. Chem. 280 (2005) 35943-35952
13. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., and Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 (1999) 597-601
14. Fulton D., Ruan L., Sood S.G., Li C., Zhang Q., and Venema R.C. Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation. Role of eNOS phosphorylation at Tyr83. Circ. Res. 102 (2008) 497-504
15. Jo S.-H., Leblais V., Wang P.H., Crow M.T., and Xiao R.-P. Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent Gs signaling during {beta}2-adrenergic stimulation. Circ. Res. 91 (2002) 46-53 10.1161/01.RES.0000024115.67561.54
16. Kou R., Greif D., and Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J. Biol. Chem. 277 (2002) 29669-29673 10.1074/jbc.M204519200
17. Lai J.P., Bao S., Davis I.C., and Knoell D.L. Inhibition of the phosphatase PTEN protects mice against oleic acid-induced acute lung injury. Br. J. Pharmacol. 156 (2009) 189-200
18. Le Good J.A., Ziegler W.H., Parekh D.B., Alessi D.R., Cohen P., and Parker P.J. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281 (1998) 2042-2045 10.1126/science.281.5385.2042
19. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
20. Lin M.I., Fulton D., Babbitt R., Fleming I., Busse R., Pritchard Jr. K.A., and Sessa W.C. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of l-arginine metabolism to efficient nitric oxide production. J. Biol. Chem. 278 (2003) 44719-44726
21. Maehama T., and Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem 273 (1998) 13375-13378
22. Marsh D.J., Kum J.B., Lunetta K.L., Bennett M.J., Gorlin R.J., Ahmed S.F., Bodurtha J., Crowe C., Curtis M.A., Dasouki M., Dunn T., Feit H., Geraghty M.T., Graham Jr. J.M., Hodgson S.V., Hunter A., Korf B.R., Manchester D., Miesfeldt S., Murday V.A., Nathanson K.L., Parisi M., Pober B., Romano C., Eng C., et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet. 8 (1999) 1461-1472
23. Michell B.J., Harris M.B., Chen Z.P., Ju H., Venema V.J., Blackstone M.A., Huang W., Venema R.C., and Kemp B.E. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J. Biol. Chem. 277 (2002) 42344-42351
24. Mount P.F., Kemp B.E., and Power D.A. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J. Mol. Cell. Cardiol. 42 (2007) 271-279
25. Myers M.P., Stolarov J.P., Eng C., Li J., Wang S.I., Wigler M.H., Parsons R., and Tonks N.K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9052-9057
26. Oudit G.Y., Sun H., Kerfant B.G., Crackower M.A., Penninger J.M., and Backx P.H. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J. Mol. Cell. Cardiol. 37 (2004) 449-471
27. Sessa W.C., Barber C.M., and Lynch K.R. Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Circ. Res. 72 (1993) 921-924
28. Shen Y.H., Zhang L., Gan Y., Wang X., Wang J., LeMaire S.A., Coselli J.S., and Wang X.L. Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells. J. Biol. Chem. 281 (2006) 7727-7736
29. Shen Y.H., Zhang L., Utama B., Wang J., Gan Y., Wang X., Chen L., Vercellotti G.M., Coselli J.S., Mehta J.L., and Wang X.L. Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovasc. Res. 69 (2006) 502-511
30. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., and Mak T.W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95 (1998) 29-39
31. Tiozzo C., De Langhe S., Yu M., Londhe V.A., Carraro G., Li M., Li C., Xing Y., Anderson S., Borok Z., Bellusci S., and Minoo P. Deletion of PTEN expands lung epithelial progenitor pools and confers resistance to Airway Injury. Am. J. Respir. Crit. Care Med. 180 8 (2009) 701-712
32. Tsigkos S., Zhou Z., Kotanidou A., Fulton D., Zakynthinos S., Roussos C., and Papapetropoulos A. Regulation of Ang2 release by PTEN/PI3-kinase/Akt in lung microvascular endothelial cells. J. Cell. Physiol. 207 (2006) 506-511
33. Wang X.L., Zhang L., Youker K., Zhang M.X., Wang J., LeMaire S.A., Coselli J.S., and Shen Y.H. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 55 (2006) 2301-2310
34. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 342 (2000) 1334-1349
35. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., Simons J.W., and Semenza G.L. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60 (2000) 1541-1545